Neuroscience under threat as Big Pharma backs off

Victor
By -
0
Scientists worried by waning commitment from major drugmakers to brain research warn the prospect for new drugs to treat diseases like Alzheimers is bleak unless regulators and governments find incentives fast.

Big Pharma is struggling to make money from neuroscience -- the science of how the brain works and affects behavior -- because research is proving unpredictable and costly at a time when companies are grappling with patent expirations and pressure to cut prices.

To read more about this issue -- go here.





Subscribe to the Alzheimer's Reading Room

Enter your email address:


Alzheimer's Disease -- Advice and Insight


Bob DeMarco is the Founder of the Alzheimer's Reading Room and an Alzheimer's caregiver. The blog contains more than 2,255 articles with more than 272,100 links on the Internet. Bob resides in Delray Beach, FL.


The Alzheimer's Action Plan

 

300 Tips for Making Life Easier



Original content Bob DeMarco, the Alzheimer's Reading Room

Post a Comment

0Comments

Post a Comment (0)